Amgen 2015 outlook could be raised on buybacks, says Deutsche Bank

theflyonthewall.com

Deutsche Bank expects Amgen to update its 2015 guidance at its business review meeting on February 7. Deutsche thinks the current 2015 earnings outlook of $7.25-$8.60 could be raised to $7.93-$9.25 due to more aggressive share buybacks. The firm notes the current consensus is at the low end of its new projected guidance range. Deutsche keeps a Buy rating on Amgen shares with a $108 price target.

View Comments (0)